EDITORIAL
Clinical trials of endothelin antagonists in heart failure: publication is good for the public health
Clinical Pharmacology Unit, Centre for Cardiovascular Science, University of Edinburgh, Queens Medical Research Institute, Edinburgh, UK
Correspondence to:
Correspondence to:
D J Webb
Clinical Pharmacology Unit, Centre for Cardiovascular Science, University of Edinburgh, Queens Medical Research Institute, 3rd Floor East Room E3.22, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; d.j.webb{at}ed.ac.uk
The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published
Abbreviations: CHF, chronic heart failure; EARTH, Endothelin A Receptor Antagonist Trial in Heart Failure; HEAT, Haemodynamic and Neurohumoral Effects of Selective Endothelin A Receptor Blockade in Chronic Heart Failure; NYHA, New York Heart Association
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Murray, D. B., Gardner, J. D., Brower, G. L., Janicki, J. S.
(2008). Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats. Am. J. Physiol. Heart Circ. Physiol.
294: H1251-H1257
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
